Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats †

Methylphenidate (MPH) is among the main drugs prescribed to treat patients with attention-deficit and hyperactivity disease (ADHD). MPH blocks both the norepinephrine and dopamine reuptake transporters (NET and DAT, respectively). Our study was aimed at further understanding the mechanisms by which...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Miceli, Mathieu, Derf, Asma, Gronier, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369023/
https://www.ncbi.nlm.nih.gov/pubmed/35955717
http://dx.doi.org/10.3390/ijms23158588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369023/
https://www.ncbi.nlm.nih.gov/pubmed/35955717
http://dx.doi.org/10.3390/ijms23158588

Ejemplares similares